AME

Business profile & competitive position

AMETEK, Inc. (AME) is classified in the Industrials sector under Electrical Equipment & Parts. It operates through two business groups: Electronic Instruments (EIG), which designs advanced analytical, test and measurement instruments for process, aerospace, power and industrial markets; and Electromechanical (EMG), which supplies precision motion control solutions, engineered medical components and devices, thermal management systems, specialty metals and electrical interconnects for aerospace, defense, medical, automation and other industrial markets. The revenue model is overwhelmingly B2B and engineered-to-specification, so its competitive position rests on technical performance, reliability and customer switching costs rather than consumer brand recognition.

The financials support a narrow but durable moat interpretation. A 20.0% net margin and 14.5% ROE sit well above typical commodity industrial manufacturers, implying that the company has some combination of pricing power, low-cost manufacturing discipline and specification lock-in. ROE in the mid-teens also suggests management is effective at converting equity into earnings. Those returns are what allow the company to absorb input-cost volatility and still compound, but they also set the table for a premium valuation that leaves limited room for operational slip.

Financial posture

At a $57.7 billion market capitalization and a P/E of 36.6, AME trades at a clear premium to the broader Industrials peer set. The 20.0% net margin and 14.5% ROE provide partial justification, while a beta of 0.99 indicates the stock has moved roughly in line with the overall market despite its industrial and aerospace exposure. As of the recent snapshot, the stock was at $251.67, above a 50-day EMA of $240.85, with an RSI of 64.1 that is elevated but not yet in overbought territory.

Taken together, the valuation says the market is treating AME as a high-quality compounder, not a deep-value cyclical. The risk embedded in a 36.6 P/E is that incremental returns now depend more on execution and consistent growth than on multiple expansion. With the next report due October 29, 2026, before the open, and the consensus EPS estimate at $2.10, the current setup implies there is little tolerance for a miss or for soft forward guidance.

Strategic priorities & outlook

AME's most recent 10-K frames its operational roadmap around the AMETEK Growth Model. The targets are specific: high-single-digit annual sales growth, double-digit annual EPS growth, strong cash flow generation and a superior return on total capital. The tools to get there are equally concrete: lean manufacturing, global sourcing, Design for Six Sigma, Value Engineering/Value Analysis, growth kaizens, digitalization and artificial intelligence.

Acquisitions are the second leg of the strategy. From 2021 through December 31, 2025, the company completed 15 acquisitions representing roughly $1.8 billion in annualized sales. In 2025 alone it spent $933.2 million in cash, net of cash acquired, to buy Kern and FARO Technologies, adding high-precision machining, optical inspection and 3D measurement capabilities. These are not random diversifications; they extend the precision-instrument platform into adjacent workflows.

The 2025 numbers give the strategy credibility. Sales were $7,401.1 million, up 6.6% from 2024, and diluted EPS came in at $6.40, up 7.9%. The company also recorded record operating income, net income, orders and backlog. International exposure is material: 52% of EIG net sales and 42% of EMG net sales went to customers outside the United States. Manufacturing facilities are located in China, Czechia, Malaysia, Mexico and Serbia, positioning the company for customer proximity and cost but also tying it to cross-border supply and demand dynamics. As of the year-end filing, AME employed approximately 22,500 people.

Macro & geopolitical exposure

As an Electrical Equipment & Parts supplier with heavy exposure to aerospace, defense, medical and automation capital spending, AME inherits the macro sensitivities of industrial capex cycles. When customers pull back on factory investment, aircraft purchases or defense programs, order flows slow. Conversely, when capex rebounds and utilization rises, demand for its analytical instruments and motion-control components typically follows.

Materials exposure also matters. Products rely on copper, specialty metals, electronic components and precision-machined parts, so shortages or sustained input-cost inflation can pressure margins unless pricing power keeps pace. Because roughly half of segment sales go outside the United States and key plants are in China, Czechia, Malaysia, Mexico and Serbia, the company is exposed to currency translation, tariffs, trade policy and regional supply-chain disruptions. Aerospace and defense budget trajectories and medical-device regulation add further end-market sensitivity. These are inherent risks of the sector and the business model, not company-specific overlays.

Recent developments

Recent headlines have reflected a mix of valuation caution and thematic optimism. On September 16, 2026, gurufocus.com ran "Is AME Overvalued? DCF Says Worth $158," questioning whether the current price leaves any margin of safety once expected cash flows are discounted. On September 3, 2026, zacks.com asked "Why Is Ametek (AME) Down 8.5% Since Last Earnings Report?", capturing a pullback that occurred even as the company continued its streak of earnings beats.

On the more bullish side, a September 17, 2026 fool.com article tied NASA's new Moon base contract to potential opportunity for the company's nuclear-power-related positioning, which fits with AME's aerospace, defense and specialized-power footprint. A September 4, 2026 Seeking Alpha note on Baron SMID Cap ETF portfolio activity pointed to institutional positioning but did not advance a company-specific thesis. The overall news cluster reads as a debate over whether the premium already priced into the stock can keep expanding after a long run of strong execution.

Earnings behavior & post-earnings drift

The earnings history is as consistent as it gets. Over the last eight reported quarters, AME has beaten estimates every time, for a 100% beat rate, with an average earnings surprise of 4%. Despite that streak, the average five-day price move after earnings across those quarters is only 0.46%, which is classified as flat. That pattern points to a market that has normalized the beat: the official estimate may be set conservatively enough that a positive surprise is the baseline rather than a catalyst.

The last four reports show the same theme. On August 4, 2026, EPS of $2.09 beat the $1.99 estimate by 5.0%, but the stock moved only 0.28% the next day and 0.89% over the following five sessions. On April 30, 2026, EPS of $1.97 beat a $1.90 estimate by 3.7%, yet the stock fell 2.13% the next day and 0.33% over five days. On February 3, 2026, EPS of $2.01 beat the $1.94 estimate by 3.6%, with a 0.48% next-day decline followed by a 1.83% gain over five days. On October 30, 2025, EPS of $1.89 beat the $1.76 estimate by 7.4%, producing a 1.91% next-day rise but a 0.54% decline over the following five sessions.

Heading into the October 29, 2026 report, the consensus EPS estimate is $2.10. Because the market's real expectation has been shaped by an eight-quarter winning streak, the printed estimate may understate the true hurdle. For post-earnings drift analysis, the key will be whether guidance, backlog and orders, not just the EPS surprise, drive the directional price move.

For a more complete picture of how institutional analysts are interpreting these earnings, valuation and strategic trends, explore the full institutional verdict on the platform.